Ceftizoxime alapivoxil

Drug Profile

Ceftizoxime alapivoxil

Alternative Names: AS 924; KY 020

Latest Information Update: 06 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kyoto Pharmaceutical Industries
  • Developer Asahi Kasei
  • Class Antibacterials; Cephalosporins; Small molecules
  • Mechanism of Action Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Bacterial infections

Most Recent Events

  • 06 Mar 2008 Discontinued - Preregistration for Bacterial infections in Japan (PO)
  • 12 Jul 2007 Development of this compound is ongoing
  • 05 Nov 2003 Preregistration for Bacterial infections in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top